Acta Crystallographica Section C Crystal Structure Communications · 2012 · 12 citations · 24 references
PharmacyMedicinal ChemistryPharmacologyChemotherapyDrug DiscoveryProdrug DesignAnticancer Prodrug DesignCrystal ChemistryChemotherapeutic Prodrug DesignCrystal Structure DeterminationCrystal Structure RefinementPowder DiffractionPowder Diffraction AnalysisPowder X-ray DiffractionPyrimidine AnaloguesPyrimidine Chemistry
Nimustine hydrochloride [systematic name: 4-amino-5-({[N-(2-chloroethyl)-N-nitrosocarbamoyl]amino}methyl)-2-methylpyrimidin-1-ium chloride], C(9)H(14)ClN(6)O(2)(+)·Cl(-), is a prodrug of CENU (chloroethylnitrosourea) and is used as a cytostatic agent in cancer therapy. Its crystal structure was determined from laboratory X-ray powder diffraction data. The protonation at an N atom of the pyrimidine ring was established by solid-state NMR spectroscopy.
24
A short history of<i>SHELX</i>
George M. Sheldrick · Acta Crystallographica Section A Foundations of Crystallography · 2007 · 87.4K citations · Full text